Medicare’s $2,100 Drug Quietly Reshapes Prescription Costs for Investors
Medicare's out-of-pocket cap for covered prescriptions rises to $2,100 in 2026, ending the donut-hole-era for many pa...
Compare daily and long-term volatility across major coins to inform allocation and risk controls in your portfolio.
20,930 articlesMedicare's out-of-pocket cap for covered prescriptions rises to $2,100 in 2026, ending the donut-hole-era for many pa...
A leading defense analyst warns of a readiness gap as U.S. munitions deliveries lag demand, signaling a multiyear bud...
Social Security's finances are under pressure as 2033 insolvency looms and a $26.1 trillion 75-year shortfall exists....
Iran asserts a new permission and insurance framework for crossing the Strait of Hormuz, while ships continue to move...
A recent Insider Form 4 reveals Nayax Ltd.'s President sold 4,500 shares after exercising options. Here’s how to read...
Oil prices surged after Iran closed the Strait of Hormuz again, renewing inflation concerns and pressuring Fed policy...
Imagine a SpaceX-scale IPO changing how investors price AI startups. This article breaks down what spacex just bigges...
A timely retrospective on alan greenspan, legendary former Fed chair, tracing policy bets, market responses, and the ...
A Magnite insider disclosed a sizable open-market sale, sparking questions for investors. This guide breaks down what...
When you see alamos gold stock plummeting, it’s often more than a minor price swing. This article breaks down the mai...
A major biotech takeover bid sets the tone for today’s market. AbbVie’s cash offer for Apogee Therapeutics sent share...
Insider moves can reveal how company insiders view the path ahead. This guide breaks down what it means when a chief ...